Bortezomib-related colon mucositis in a multiple myeloma patient

被引：13
作者：
Siniscalchi, Agostina [1 ]
Tendas, Andrea [1 ]
Ales, Micaela [1 ]
Fratoni, Stefano [2 ]
Cupelli, Luca [1 ]
Dentamaro, Teresa [1 ]
Scaramucci, Laura [1 ]
Giovannini, Marco [1 ]
Caravita, Tommaso [1 ]
Santeusanio, Giuseppe [2 ]
Niscola, Pasquale [1 ]
de Fabritiis, Paolo [1 ]
机构：
[1] Univ Roma Tor Vergata, Div Haematol, St Eugenio Hosp, Rome, Italy
[2] Univ Roma Tor Vergata, Dept Pathol, St Eugenio Hosp, Rome, Italy
来源：
SUPPORTIVE CARE IN CANCER | 2009年 / 17卷 / 04期
关键词：
Multiple Myeloma; Bortezomib; Autonomic Neuropathy; Severe Renal Failure; Damage Pathway;
D O I：
10.1007/s00520-008-0573-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：325 / 327
页数：3
相关论文
共 50 条
  • [1] Bortezomib-related colon mucositis in a multiple myeloma patient
    Agostina Siniscalchi
    Andrea Tendas
    Micaela Ales
    Stefano Fratoni
    Luca Cupelli
    Teresa Dentamaro
    Laura Scaramucci
    Marco Giovannini
    Tommaso Caravita
    Giuseppe Santeusanio
    Pasquale Niscola
    Paolo de Fabritiis
    Supportive Care in Cancer, 2009, 17 : 325 - 327
  • [2] The Effect of Docosahexaenoic Acid and α-Lipoic Acid as Prevention of Bortezomib-Related Neurotoxicity in Patients With Multiple Myeloma
    Maschio, Marta
    Zarabla, Alessia
    Maialetti, Andrea
    Marchesi, Francesco
    Giannarelli, Diana
    Gumenyuk, Svitlana
    Pisani, Francesco
    Renzi, Daniela
    Galie, Edvina
    Mengarelli, Andrea
    INTEGRATIVE CANCER THERAPIES, 2019, 18
  • [3] Prevention of Bortezomib-Related Peripheral Neuropathy With Docosahexaenoic Acid and α-Lipoic Acid in Patients With Multiple Myeloma: Preliminary Data
    Maschio, Marta
    Zarabla, Alessia
    Maialetti, Andrea
    Marchesi, Francesco
    Giannarelli, Diana
    Gumenyuk, Svitlana
    Pisani, Francesco
    Renzi, Daniela
    Galie, Edvina
    Mengarelli, Andrea
    INTEGRATIVE CANCER THERAPIES, 2018, 17 (04) : 1115 - 1124
  • [4] Pneumonitis associated with bortezomib in a patient with multiple myeloma
    Kars, Taha Ulutan
    Yaskiran, Osman
    Ceneli, Ozcan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (04) : 1021 - 1024
  • [5] Real-world incidence and risk factors of bortezomib-related cardiovascular adverse events in patients with multiple myeloma
    Jang, Bitna
    Jeong, Jonghyun
    Heo, Kyu-Nam
    Koh, Youngil
    Lee, Ju-Yeun
    BLOOD RESEARCH, 2024, 59 (01)
  • [6] Bortezomib induced a phrenic palsy in a multiple myeloma patient
    Vitalie Nizeica
    Philippe Collet
    Hubert Marotte
    Annals of Hematology, 2013, 92 : 1135 - 1136
  • [7] Bortezomib in multiple myeloma
    Terpos, Evangelos
    Roussou, Maria
    Dimopoulos, Meletios-Athanassios
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (05) : 639 - 654
  • [8] Bortezomib in multiple myeloma
    Mateos, M. V.
    Miguel, J. F. San
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) : 701 - 715
  • [9] Bortezomib-induced perivascular dermatitis in a patient with multiple myeloma
    Ozkurt, Zubeyde Nur
    Sucak, Guelsan Tuerkoez
    Aki, Sahika Zeynep
    Yagci, Muenci
    Erdem, Oezlem
    CUTANEOUS AND OCULAR TOXICOLOGY, 2009, 28 (03) : 141 - 143
  • [10] Meibomian Gland Dysfunction Associated with Bortezomib in a Multiple Myeloma Patient
    Yoon, Da Eun
    Jun, Roo Min
    Han, Kyung Eun
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2022, 63 (04): : 389 - 395
12345